Skinvisible (SKVI) Return on Sales [ROS] (2010 - 2026)
Skinvisible's Return on Sales [ROS] came in at -2256.34% for Q2 2026, up 468.40 percentage points from -2724.74% a year earlier and up 262.42 percentage points from the prior quarter.
Powered by 
Analysis
Skinvisible (SKVI) Return on Sales [ROS] (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Skinvisible reported Return on Sales [ROS] of -2294.91%, up 704.10 percentage points year-over-year; for FY2025, it came in at -2481.58%, up 466.37 percentage points from FY2024.
- Return on Sales [ROS] carries a five-year change of -2315.38 percentage points (FY2020 to FY2025).
- Going back by year, Return on Sales [ROS] was -2947.95% in FY2024 (-496.07 pp), -2451.88% in FY2023 (-2366.51 pp), -85.37% in FY2022 (-113.72 pp) and 28.35% in FY2021 (+194.54 pp).
- The five-year range for quarterly Return on Sales [ROS] is -3974.86% (Q4 2024) to 58.35% (Q4 2021).
- Year-over-year, Return on Sales [ROS] has increased for five consecutive quarters, with an average year-over-year change of +141.36 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Sales [ROS] over five years came in Q3 2021 (a gain of 2828.76 percentage points), and the weakest in Q1 2023 (a drop of 2425.47 percentage points).
- Business Quant data shows SKVI's Return on Sales [ROS] at -2518.76% (Q1 2026), -2283.38% (Q4 2025) and -2121.14% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Skinvisible | 1.08 Mn | 1.07 Mn | 5,000.00 | -2,256.34% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,256.34% |
| Mar 31, 2026 | -2,518.76% |
| Dec 31, 2025 | -2,283.38% |
| Sep 30, 2025 | -2,121.14% |
| Jun 30, 2025 | -2,724.74% |
| Mar 31, 2025 | -2,797.04% |
| Dec 31, 2024 | -3,974.86% |
| Sep 30, 2024 | -2,499.38% |
| Jun 30, 2024 | -2,853.86% |
| Mar 31, 2024 | -2,463.68% |
| Dec 31, 2023 | -2,730.76% |
| Sep 30, 2023 | -2,262.20% |
| Jun 30, 2023 | -2,256.46% |
| Mar 31, 2023 | -2,558.08% |
| Dec 31, 2022 | -2,354.32% |
| Sep 30, 2022 | -1,365.04% |
| Jun 30, 2022 | 41.95% |
| Mar 31, 2022 | -132.61% |
| Dec 31, 2021 | 58.35% |
| Sep 30, 2021 | -7.05% |
API Access
Skinvisible Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SKVI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "SKVI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SKVI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();